Literature DB >> 2581247

Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.

K Ozato, Y J Wan, B M Orrison.   

Abstract

To determine the timing of major histocompatibility complex class I gene expression during embryonic development, binding of anti-class I antibodies and appearance of class I gene transcripts were examined in mouse embryos from the egg-cylinder stage through day 16 of gestation. By using two series of monoclonal antibodies reactive with monomorphic and polymorphic determinants of class I antigens, it was found that cell-surface expression of the antigens becomes detectable at a low level only after midsomite stage on gestation day 10, at a time when embryos are developed beyond primordial organogenesis and have partial blood circulation. In agreement with the above finding, a low level of class I mRNA became detectable in day 9 and older embryos in blot hybridization. The level of class I transcripts in embryos at least to day 13 remained less than 1/50th that in adult spleen cells. Cells from head-fold stage embryos (gestation day 8), which otherwise do not have an appreciable amount of class I mRNA or surface antigens, begin to express a high level of antigens upon treatment with mouse alpha/beta or gamma interferon. This induction of class I antigen expression appears to be stage specific in that embryos in an earlier egg-cylinder stage (day 6) failed to express the antigens after interferon treatment. A possible role of interferons in activating class I genes during in vivo embryonic development is suggested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581247      PMCID: PMC397571          DOI: 10.1073/pnas.82.8.2427

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells.

Authors:  D Morello; G Gachelin; P Dubois; N Tanigaki; D Pressman; F Jacob
Journal:  Transplantation       Date:  1978-08       Impact factor: 4.939

2.  The antiproliferative effects of interferon on murine embryonic cells.

Authors:  K Drasner; C J Epstein; L B Epstein
Journal:  Proc Soc Exp Biol Med       Date:  1979-01

3.  The presence of F9 antigen on the surface of mouse embryonic cells until day 8 of embryogenesis.

Authors:  M H Buc-Caron; H Condamine; F Jacob
Journal:  J Embryol Exp Morphol       Date:  1978-10

4.  The original function of MHC antigens as the general plasma membrane anchorage site of organogenesis-directing proteins.

Authors:  S Ohno
Journal:  Immunol Rev       Date:  1977-01       Impact factor: 12.988

5.  Embryo growth and differentiation factors in embryonic sera of mammals.

Authors:  Y C Hsu
Journal:  Dev Biol       Date:  1980-05       Impact factor: 3.582

6.  Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon.

Authors:  I Heron; M Hokland; K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

8.  Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells.

Authors:  P S Steeg; R N Moore; J J Oppenheim
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

9.  Synthesis and distribution of H-2 antigens in preimplantation mouse embryos.

Authors:  C G Webb; W E Gall; G M Edelman
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

10.  Detection of alloantigens during preimplantation development and early trophoblast differentiation in the mouse by immunoperoxidase labeling.

Authors:  R F Searle; M H Sellens; J Elson; E J Jenkinson; W D Billington
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

View more
  66 in total

1.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

Authors:  J R Flanagan; M Murata; P A Burke; Y Shirayoshi; E Appella; P A Sharp; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  PC12 cells differentiate into chromaffin cell-like phenotype in coculture with adrenal medullary endothelial cells.

Authors:  Y Mizrachi; J R Naranjo; B Z Levi; H B Pollard; P I Lelkes
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Developmental failure of chimeric embryos expressing high levels of H-2Dd transplantation antigens.

Authors:  L Jaffe; E J Robertson; E K Bikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

4.  Transcriptional selectivity in early mouse embryos: a qualitative study.

Authors:  C Bonnerot; M Vernet; G Grimber; P Briand; J F Nicolas
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

5.  Developmental and tissue-specific expression of the Q5k gene.

Authors:  S Schwemmle; D Bevec; G Brem; M B Urban; P A Baeuerle; E H Weiss
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice.

Authors:  J W Chamberlain; H A Vasavada; S Ganguly; S M Weissman
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Developmental expression of autoimmune target antigens during organogenesis.

Authors:  T Akashi; Y Eishi
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Lack of correlation of immunosuppressive activity secreted by human in vitro fertilized (IVF) ova with successful pregnancy.

Authors:  D T Armstrong; G Chaouat; A Guichard; L Cedard; G Andreu; L Denver
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-02

9.  Fetal allograft survival in immunocompetent recipients is age dependent and organ specific.

Authors:  R P Foglia; J DiPreta; M B Statter; P K Donahoe
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

10.  Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells.

Authors:  A Israel; O Yano; F Logeat; M Kieran; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.